Boston Heart Diagnostics is pleased to announce the availability of the Polygenic Risk MapTM. These genetic tests leverage Polygenic Risk Scores (PRS) to provide healthcare providers with a much more precise understanding of their patient’s absolute genetic risk of complex disease, allowing for the creation of early, personalized intervention strategies.
Read the full press release here: